Back to search
Hemangioma, Cavernous, Central Nervous System
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hemangioma, Cavernous, Central Nervous System trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hemangioma, Cavernous, Central Nervous System trials you may qualify forThe goal of this observational study is to evaluate and predict the risk associated with cerebral cavernous malformations (CCMs) using advanced artificial intel…
Patients with symptomatic and asymptomatic familial cerebral cavernous malformation (fCCM) will be included. The goal of this observational study is to learn ab…
Objective of the study is to determine possibilities of intraoperative sonography in detecting of various brain mass lesions, assessing extent of their resectio…
The purpose of the study is to calculate magnitude, type of intraoperative brain shift and assess possibility of it's prediction.
Cerebral cavernous malformation (CCM)-related epilepsy (CRE) impairs the quality of life in patients with CCM. Patients could not always achieve seizure freedom…
This phase I/II randomized, placebo-controlled, double-blinded, single-site clinical trial is designed to investigate the effect of a prolonged course of atorva…
The project aims to develop prognostic and diagnostic blood tests for symptomatic brain hemorrhage in patients diagnosed with cavernous angiomas, a critical cli…
This is a two-part, multi-center, randomized, double-blind, placebo-controlled study to investigate the safety, efficacy and pharmacokinetics of REC-994 (200 mg…